Text
01
Project Business Scenario and Risk Management
THIREKS Based on science, inspired by medicine
Examiner: Prof. Dr. Ing. Stefanie Wrobel Ms. Christina Moser
Presented by: Hemal Talaviya (00129932) Pablo Gomez (00129447) Shubham Patel (00129325) Nagma Sheikh (00128945) Krishna Thapa (00128951)
02
AGENDA Points for discussion
All About Startup
02 01
AGENDA Points for discussion
All About Startup
Trend Research
02
AGENDA Points for discussion
All About Startup
Trend Research
Trend Evaluation
02
AGENDA Points for discussion
All About Startup
Trend Research
Trend Evaluation
Business Scenario - 2025
02
AGENDA Points for discussion
All About Startup
Trend Research
Trend Evaluation
Business Scenario - 2025
Risk Identification and Assessment
02
AGENDA Points for discussion
All About Startup
Trend Research
Trend Evaluation
Business Scenario - 2025
Risk Identification and Assessment
Risk Mitigation
Hemal Talaviya (00129932)
02
AGENDA Points for discussion
All About Startup
Trend Research
Trend Evaluation
Business Scenario - 2025
Risk Identification and Assessment
Risk Mitigation
03
Welcome to THIREKS THIREKS introduces a novel technology: virtual randomized controlled trials, in analogy to evidence-based medicine, to predict the impacts of traffic measures, assistance systems, and automated driving. THIREKS is a stochastic simulationpowered solution to predict impacts while saving resources. THIREKS provides large, validated, representative, virtual datasets to support optimization and evidence-based safeguarding.
Hemal Talaviya (00129932)